3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
US6696448B2 · kind B2 · utility
45Cited by
9References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 2002 |
| Grant date | Feb 24, 2004 |
| Priority date | — |
| Expiry date | Jul 24, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG06F13/4045
- WIPO fieldComputer technology
- WIPO sectorElectrical engineering
Abstract
The present invention relates to novel 3-(piperazinyl-benylidenyl)-2-indolinone compounds and derivatives and physiologically acceptable salts thereof which are expected to modulate the activity of protein tyrosine kinases and therefore to be useful in the prevention and treatment of protein tyrosine kinase related cellular disorders such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.